Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma

被引:32
作者
Gehringer, Franziska [1 ]
Weissinger, Stephanie Ellen [2 ]
Moeller, Peter [2 ]
Wirth, Thomas [1 ]
Ushmorov, Alexey [1 ]
机构
[1] Univ Ulm, Inst Physiol Chem, Ulm, Germany
[2] Univ Ulm, Inst Pathol, Ulm, Germany
关键词
NF-KAPPA-B; GERMINAL CENTER LIGHT; CELL LYMPHOMA; THERAPEUTIC TARGETS; FOXO1; MUTATIONS; AKT; MYC; EXPRESSION; KINASE; PTEN;
D O I
10.1038/s41375-019-0628-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In addition to oncogenic MYC translocations, Burkitt lymphoma (BL) depends on the germinal centre (GC) dark zone (DZ) B cell survival and proliferation programme, which is characterized by relatively low PI3K-AKT activity. Paradoxically, PI3K-AKT activation facilitates MYC-driven lymphomagenesis in mice, and it has been proposed that PI3K-AKT activation is essential for BL. Here we show that the PI3K-AKT activity in primary BLs and BL cell lines does not exceed that of human non-neoplastic tonsillar GC DZ B cells. BLs were not sensitive to AKT1 knockdown, which induced massive cell death in pAKT(high) DLBCL cell lines. Likewise, BL cell lines show low sensitivity to pan-AKT inhibitors. Moreover, hyper-activation of the PI3K-AKT pathway by overexpression of a constitutively active version of AKT (myrAKT) or knockdown of PTEN repressed the growth of BL cell lines. This was associated with increased AKT phosphorylation, NF-kappa B activation, and downregulation of DZ genes including the proto-oncogene MYB and the DZ marker CXCR4. In contrast to GCB-DLBCL, PTEN overexpression was tolerated by BL cell lines. We conclude that the molecular mechanisms instrumental to guarantee the survival of normal DZ B cells, including the tight regulation of the PTEN-PI3K-AKT axis, also operate in the survival/proliferation of BL.
引用
收藏
页码:857 / 871
页数:15
相关论文
共 60 条
[1]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[2]   Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt [J].
Bai, Dong ;
Ueno, Lynn ;
Vogt, Peter K. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (12) :2863-2870
[3]   Tracking CD40 signaling during germinal center development [J].
Basso, K ;
Klein, U ;
Niu, HF ;
Stolovitzky, GA ;
Tu, YH ;
Califano, A ;
Cattoretti, G ;
Dalla-Favera, R .
BLOOD, 2004, 104 (13) :4088-4096
[4]  
Bhatti Maria, 2018, Oncotarget, V9, P21820, DOI 10.18632/oncotarget.25072
[5]   Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets [J].
Bouska, Alyssa ;
Bi, Chengfeng ;
Lone, Waseem ;
Zhang, Weiwei ;
Kedwaii, Ambreen ;
Heavican, Tayla ;
Lachel, Cynthia M. ;
Yu, Jiayu ;
Ferro, Roberto ;
Eldorghamy, Nanees ;
Greiner, Timothy C. ;
Vose, Julie ;
Weisenburger, Dennis D. ;
Gascoyne, Randy D. ;
Rosenwald, Andreas ;
Ott, German ;
Campo, Elias ;
Rimsza, Lisa M. ;
Jaffe, Elaine S. ;
Braziel, Rita M. ;
Siebert, Reiner ;
Miles, Rodney R. ;
Dave, Sandeep ;
Reddy, Anupama ;
Delabie, Jan ;
Staudt, Louis M. ;
Song, Joo Y. ;
McKeithan, Timothy W. ;
Fu, Kai ;
Green, Michael ;
Chan, Wing C. ;
Iqbal, Javeed .
BLOOD, 2017, 130 (16) :1819-1831
[6]   Akt1 and Akt2 promote peripheral B-cell maturation and survival [J].
Calamito, Marco ;
Juntilla, Marisa M. ;
Thomas, Matthew ;
Northrup, Daniel L. ;
Rathmell, Jeffrey ;
Birnbaum, Morris J. ;
Koretzky, Gary ;
Allman, David .
BLOOD, 2010, 115 (20) :4043-4050
[7]   Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK [J].
Dan, Han C. ;
Cooper, Matthew J. ;
Cogswell, Patricia C. ;
Duncan, Joseph A. ;
Ting, Jenny P. -Y. ;
Baldwin, Albert S. .
GENES & DEVELOPMENT, 2008, 22 (11) :1490-1500
[8]   Molecular diagnosis of Burkitt's lymphoma [J].
Dave, Sandeep S. ;
Fu, Kai ;
Wright, George W. ;
Lam, Lloyd T. ;
Kluin, Philip ;
Boerma, Evert-Jan ;
Greiner, Timothy C. ;
Weisenburger, Dennis D. ;
Rosenwald, Andreas ;
Ott, German ;
Mueller-Hermelink, Hans-Konrad ;
Gascoyne, Randy D. ;
Delabie, Jan ;
Rimsza, Lisa M. ;
Braziel, Rita M. ;
Grogan, Thomas M. ;
Campo, Elias ;
Jaffe, Elaine S. ;
Dave, Bhavana J. ;
Sanger, Warren ;
Bast, Martin ;
Vose, Julie M. ;
Armitage, James O. ;
Connors, Joseph M. ;
Smeland, Erlend B. ;
Kvaloy, Stein ;
Holte, Harald ;
Fisher, Richard I. ;
Miller, Thomas P. ;
Montserrat, Emilio ;
Wilson, Wyndham H. ;
Bahl, Manisha ;
Zhao, Hong ;
Yang, Liming ;
Powell, John ;
Simon, Richard ;
Chan, Wing C. ;
Staudt, Louis M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23) :2431-2442
[9]   Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background [J].
Davies, Barry R. ;
Greenwood, Hannah ;
Dudley, Phillippa ;
Crafter, Claire ;
Yu, De-Hua ;
Zhang, Jingchuan ;
Li, Jing ;
Gao, Beirong ;
Ji, Qunsheng ;
Maynard, Juliana ;
Ricketts, Sally-Ann ;
Cross, Darren ;
Cosulich, Sabina ;
Chresta, Christine C. ;
Page, Ken ;
Yates, James ;
Lane, Clare ;
Watson, Rebecca ;
Luke, Richard ;
Ogilvie, Donald ;
Pass, Martin .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) :873-887
[10]   Dynamics of B cells in germinal centres [J].
De Silva, Nilushi S. ;
Klein, Ulf .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (03) :137-148